Effects of intraperitoneally administered L-histidine on food intake, taste, and visceral sensation in rats

Disturbed hippocampal histidine metabolism contributes to cognitive impairment induced by recurrent nonsevere hypoglycemia in diabetes

Hypoglycemia is a common adverse reaction to glucose-lowering treatment. Diabetes mellitus (DM) combined with recurrent nonsevere hypoglycemia (RH) can accelerate cognitive decline. Currently, the metabolic pattern changes in cognition-related brain regions caused by this combined effect of DM and RH (DR) remain unclear. In this study, we first characterized the metabolic profiles of the hippocampus in mice exposed to DR using non-targeted metabolomic platforms. Our results showed that DR induced a unique metabolic pattern in the hippocampus, and several significant differences in metabolite levels belonging to the histidine metabolism pathway were discovered. Based on these findings, in the follow-up experiment, we found that histidine treatment could attenuate the cognitive impairment and rescue the neuronal and synaptic damage induced by DR in the hippocampus, which are closely related to ameliorated mitochondrial injury. These findings provide new insights into the metabolic mechanisms of the hippocampus in the progression of DR, and l-histidine supplementation may be a potential metabolic therapy in the future.

Effects of area postrema lesions and bilateral subdiaphragmatic afferent vagotomy on emetine-induced conditioned taste avoidance in rats

We investigated the effect of area postrema lesions and selective vagotomy of afferent fibers on emetine-induced nausea in rats. We evaluated the acquisition of the conditioned taste avoidance (CTA) to 0.1% saccharin solution after conditioning with emetine dihydrochloride (5.54 mg/kg, i.p., 1% BW). The CTA was measured in three groups of rats: a bilateral subdiaphragmatic afferent vagotomy group, an area postrema lesion group, and a sham lesion group. The bilateral vagotomy and sham groups of rats showed acquisition of CTA within 2 days of the test date. Taste avoidance was never conditioned in the area postrema lesion group. These results indicate that the area postrema plays a crucial role in the induction of emetine-induced nausea.

Effects of methyl methacrylate on the excitability of the area postrema neurons in rats

OBJECTIVES

The aim of the present study is to demonstrate the effects of inhaled methyl methacrylate (MMA) on the excitability of neurons in the area postrema (AP). We also investigated the relation between vagal afferent inputs and responding cells in the AP.

METHODS

We set up two groups of experimental animals, such as rats inhaling MMA and rats inhaling room air. To visualize the changes of AP neuron excitability after inhalation of MMA for 90 min, c-Fos protein expression was identified and quantified by immunohistochemical analysis. Some rats receiving ventral gastric branch vagotomy were also subjected to the abovementioned experiment.

RESULTS

The number of c-Fos-immunoreactive (Fos-ir) cells in the MMA group was more than six times greater than that of the control group (statistically significant, p < 0.01). In vagotomized rats inhaling MMA, markedly smaller number of Fos-ir cells was identified in the AP compared to that of rats inhaling MMA without vagotomy.

CONCLUSIONS

These results indicate that inhalation of MMA increases neuronal excitability in the AP, suggesting that vagal afferent inputs are involved in the induction mechanism of Fos-ir cells by MMA.

Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement

L-histidine (HIS) is an essential amino acid with unique roles in proton buffering, metal ion chelation, scavenging of reactive oxygen and nitrogen species, erythropoiesis, and the histaminergic system. Several HIS-rich proteins (e.g., haemoproteins, HIS-rich glycoproteins, histatins, HIS-rich calcium-binding protein, and filaggrin), HIS-containing dipeptides (particularly carnosine), and methyl- and sulphur-containing derivatives of HIS (3-methylhistidine, 1-methylhistidine, and ergothioneine) have specific functions. The unique chemical properties and physiological functions are the basis of the theoretical rationale to suggest HIS supplementation in a wide range of conditions. Several decades of experience have confirmed the effectiveness of HIS as a component of solutions used for organ preservation and myocardial protection in cardiac surgery. Further studies are needed to elucidate the effects of HIS supplementation on neurological disorders, atopic dermatitis, metabolic syndrome, diabetes, uraemic anaemia, ulcers, inflammatory bowel diseases, malignancies, and muscle performance during strenuous exercise. Signs of toxicity, mutagenic activity, and allergic reactions or peptic ulcers have not been reported, although HIS is a histamine precursor. Of concern should be findings of hepatic enlargement and increases in ammonia and glutamine and of decrease in branched-chain amino acids (valine, leucine, and isoleucine) in blood plasma indicating that HIS supplementation is inappropriate in patients with liver disease.

Effects of standardized ileal digestible histidine to lysine ratio on growth performance of 7- to 11-kg nursery pigs

Histidine may be the sixth limiting amino acid (AA) in practical nursery diets supplemented with high amounts of feed-grade AA. Therefore, 2 experiments were conducted to determine the standardized ileal digestible (SID) His:Lys ratio requirement estimate for growth performance of 7- to 11-kg nursery pigs. A total of 360 and 350 pigs (DNA 241 × 600, Columbus, NE; initially 7.1 ± 0.31 and 6.6 ± 0.36 kg) were used in Exp. 1 and 2, respectively. There were 5 pigs per pen with 12 replicates per treatment in Exp. 1 and 10 replicates per treatment in Exp. 2. After weaning, pigs were fed a common pelleted diet for 10 d in Exp. 1 and 7 d in Exp. 2. Then, pens were assigned to treatments in a randomized complete block design with body weight (BW) as the blocking factor. Dietary treatments consisted of SID His:Lys ratios of 24%, 28%, 32%, 36%, 40%, and 44% in Exp. 1 and 24%, 28%, 30%, 32%, 34%, 36%, and 42% in Exp. 2. Experimental diets were fed in pellet form for 10 or 14 d in Exp. 1 and 2, followed by a common mash diet for 15 or 14 d, respectively. Data were analyzed using the GLIMMIX and NLMIXED procedures of SAS, fitting data with heterogeneous variance when needed. The competing statistical models utilized were quadratic polynomial, broken-line linear (BLL), and broken-line quadratic. In Exp. 1, increasing SID His:Lys ratio increased (quadratic, P = 0.001) ADG, ADFI, G:F, and day 10 BW. In Exp. 2, ADG, G:F, and day 14 BW increased (quadratic, P = 0.001), and ADFI increased linearly (P = 0.001) with increasing SID His:Lys ratio. The best-fitting model for all response variables analyzed was the BLL. In Exp. 1, requirement estimates were 29.7%, 29.1%, and 29.8% SID His:Lys ratio for ADG, ADFI, and G:F, respectively. In Exp. 2, the SID His:Lys ratio requirement estimates were 31.0% for ADG and 28.6% for G:F. These results suggest that the SID His requirement estimate for growth performance is no more than 31% of Lys and that the NRC (2012) SID His requirement of 34% of Lys may be overestimated for 7- to 11-kg pigs.